Literature DB >> 3008906

Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.

J van der Meer, S Daenen, G W van Imhoff, J T de Wolf, M R Halie.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3008906      PMCID： PMC1340114          DOI： 10.1136/bmj.292.6527.1049

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIII concentrate.

Authors:  C Rouzioux; S Chamaret; L Montagnier; V Carnelli; G Rolland; P M Mannucci
Journal:  Lancet       Date:  1985-02-02       Impact factor: 79.321

2.  Seroconversion of human T cell lymphotrophic virus III (HTLV-III) in patients with haemophilia: a longitudinal study.

Authors:  S E Ball; J M Hows; A M Worsley; L Luzzatto; A C Chu; R Meacham; J Morris; R Cheingsong-Popov; R A Weiss; R Tedder
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

3.  HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.

Authors:  M Melbye; K S Froebel; R Madhok; R J Biggar; P S Sarin; S Stenbjerg; G D Lowe; C D Forbes; J J Goedert; R C Gallo
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

4.  Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.

Authors:  J S McDougal; L S Martin; S P Cort; M Mozen; C M Heldebrant; B L Evatt
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808
  4 in total
  2 in total

1.  HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.

Authors:  R S Remis; M V O'Shaughnessy; C Tsoukas; G H Growe; M T Schechter; R W Palmer; D N Lawrence
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

2.  Heat treatment for endocrinological investigations on plasma positive for human immunodeficiency virus (HIV).

Authors:  M R Hancock; M L Knapp; H C Ghany; P D Mayne
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.